Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 8,160.00
+370.00 (4.75%)
At close: Aug 7, 2026
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 174.9 billion as of August 7, 2026. Its market cap has decreased by -37.71% in one year.
Market Cap
174.90B
Enterprise Value
312.23B
Revenue
605.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,160.00
ChartMarket Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 174.90B, an increase of 868.42%. That is a compound annual growth rate of 9.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 174.90B | -31.72% |
| Dec 30, 2025 | 256.13B | -16.14% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FutureChem Co.,Ltd | 196.64B |
| Whan In Pharm | 192.23B |
| Chong Kun Dang Holdings | 190.42B |
| REYON Pharmaceutical | 183.96B |
| JW Lifescience | 178.23B |
| BNC KOREA | 177.83B |
| Hyundai Pharmaceutical | 170.22B |
| Daihan Pharmaceutical | 158.76B |